National Institutes Of Health
-
School of Medicine Basic Sciences among nation’s top NIH-funded departments with more than $65 million in FY2023; cell and developmental biology No. 3 nationally
Vanderbilt’s cell and developmental biology department is the third-most NIH-funded in the nation. Biochemistry, pharmacology, and molecular physiology and biophysics are in the top 15. Read MoreMay. 7, 2024
-
Hinton lab maps structure of mitochondria at different life stages
Antentor Hinton Jr. spearheaded a collaboration with labs from across Vanderbilt University, the U.S., and Brazil to create 3D maps of mitochondria inside brown adipose tissue, which may help researchers identify potential therapies to treat metabolic ailments. Read MoreApr. 4, 2024
-
Vanderbilt biochemists contribute to breakthrough discovery of first new antibacterial class in decades
Led by Neil Osheroff, Vanderbilt researchers are the first to undertake a systematic analysis of the mechanism of action of geoptidacin. Gepotidacin is poised to become the first new class of antibacterials to be approved for use in humans in decades. Read MoreMar. 26, 2024
-
Q&A: Illuminating a critical step in initiating DNA replication in eukaryotes
Brandt Eichman and Walter Chazin, professors of biochemistry, worked together to provide a better understanding of how exactly DNA replication is initiated. Their work will influence novel small molecule modifier designs that may serve as tools for detailed studies of DNA replication in cells and eventual therapies. Read MoreMar. 15, 2024
-
Cell and Developmental Biology pushes the limits of cancer research
If you had visited Vanderbilt nearly a century ago searching for cellular research, you would have found yourself in the Department of Anatomy. Established in 1925, the Department of Anatomy gave way to the Department of Cell Biology before taking on its current moniker—Cell and Developmental Biology—in 2001. Read MoreMar. 7, 2024
-
Vanderbilt biochemists discover breakthrough evolution-resistant compound to combat antibiotic resistance
The World Health Organization ranks antimicrobial resistance as one of the top ten global health risks. Vanderbilt researchers led by Houra Merrikh identified the first anti-evolution compound that targets AMR during treatment of infections with antibiotics. Read MoreFeb. 26, 2024
-
Biomedical Ph.D. alumni career goals and outcomes revealed in new research
New research from the Office of Biomedical Research Education and Training connects the dots between career goals during graduate school and career outcomes, articulates how careers of Ph.D. alumni evolve during the 10 years after graduation. Read MoreOct. 24, 2023
-
Renã Robinson receives National Institutes of Health grant for faculty success program to promote equity in science
Renã Robinson, Dorothy Wingfield Phillips Chancellor’s Faculty Fellow and professor of chemistry, received $2.04 million in funding from the National Institutes of Health to start a program that will help underrepresented minority faculty further their success in STEM. Collaborators on the grant include researchers from the University of Kentucky and… Read MoreJan. 18, 2023